Assessing effectiveness of aripiprazole lauroxil vs placebo for the treatment of schizophrenia using number needed to treat and number needed to harm.

MLA

Citrome, Leslie, et al. “Assessing Effectiveness of Aripiprazole Lauroxil vs Placebo for the Treatment of Schizophrenia Using Number Needed to Treat and Number Needed to Harm.” Neuropsychiatric Disease & Treatment, vol. 15, Sept. 2019, pp. 2639–46. EBSCOhost, https://doi.org/10.2147/NDT.S207910.

APA

Citrome, L., Du, Y., & Weiden, P. J. (2019). Assessing effectiveness of aripiprazole lauroxil vs placebo for the treatment of schizophrenia using number needed to treat and number needed to harm. Neuropsychiatric Disease & Treatment, 15, 2639–2646. https://doi.org/10.2147/NDT.S207910

Chicago

Citrome, Leslie, Yangchun Du, and Peter J Weiden. 2019. “Assessing Effectiveness of Aripiprazole Lauroxil vs Placebo for the Treatment of Schizophrenia Using Number Needed to Treat and Number Needed to Harm.” Neuropsychiatric Disease & Treatment 15 (September): 2639–46. doi:10.2147/NDT.S207910.